Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study

✍ Scribed by Ballantyne, Christie M.; Hoogeveen, Ron C.; Raya, Joe L.; Cain, Valerie A.; Palmer, Mike K.; Karlson, Björn W.

• Book ID: 122155614
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 782 KB
• Volume: 232
• Category: Article
• ISSN: 0021-9150
• DOI: 10.1016/j.atherosclerosis.2013.10.022